D64.81 Billable / specific Anemia due to antineoplastic chemotherapy

ICD-10-CM D64.81 identifies “Anemia due to antineoplastic chemotherapy” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Code-level instructions

Inclusion terms1

Antineoplastic chemotherapy induced anemia

Excludes 22
  • anemia in neoplastic disease (D63.0)
  • aplastic anemia due to antineoplastic chemotherapy (D61.1)

Inherited instructions

Chapters 3 · Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

Excludes 29
  • autoimmune disease (systemic) NOS (M35.9)
  • certain conditions originating in the perinatal period (P00-P96)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • human immunodeficiency virus [HIV] disease (B20)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

D64 · Other anemias

Excludes 12
  • refractory anemia (D46.-)
  • refractory anemia with excess blasts in transformation [RAEB T] (C92.0-)
Official index references

Official index references (2)

Anemia(essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) (2)
References from other codes (1)
History

Code history

Latest recorded change · FY2022

ChangedUnchanged
FY2022

Effective from

  • Code-level rules changed

Anemia due to antineoplastic chemotherapy

Billable diagnosis code

CDC/NCHS · FY2022

All editions (19)

All editionsEffective fromCode history
FY20162015-10-01First observed
FY20172016-10-01Code-level rules changed
FY20182017-10-01No tabular change
FY20192018-10-01No tabular change
FY20202019-10-01No tabular change
FY2020 · April2020-04-01No tabular change
FY20212020-10-01No tabular change
FY2021 · 01-012021-01-01No tabular change
FY20222021-10-01Code-level rules changed
FY2022 · 04-012022-04-01No tabular change
FY20232022-10-01No tabular change
FY2023 · 04-012023-04-01No tabular change
FY20242023-10-01No tabular change
FY2024 · 04-012024-04-01No tabular change
FY20252024-10-01No tabular change
FY2025 · 04-012025-04-01No tabular change
FY20262025-10-01No tabular change
FY2026 · April2026-04-01No tabular change
FY20272026-10-01No tabular change
Historical ICD-9 mappings · 2018

Historical mapping only; not an automatic code substitution.

  • 285.3

This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.